lobbying_activities: 1369508

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1369508	4cda8b91-22fb-4707-a781-0f269189796f	Q1	AGILENT TECHNOLOGIES, INC	54051	AGILENT TECHNOLOGIES INC	2013	first_quarter	CHM	S. 847, Safe Chemicals Act of 2011, (112th and 113th Congress) Section 30. Reduction of Animal-Based Testing. H.R. 2521 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals S.1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals	Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE		10014	0	0	2013-04-08T17:46:14.447000-04:00